Cetera Investment Advisers
BMY icon

Cetera Investment Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Cetera Investment Advisers’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$315 Hold
100
– – ﹤0.01% 4777
2025
Q4 		$2 Buy
+100
New +$4.81K ﹤0.01% 4684
2025
Q1 		– Sell
-2,600
Closed -$3.67K – 3988
2024
Q4 		$3.67K Buy
+2,600
New +$145K ﹤0.01% 3746
2023
Q2 		– Sell
-100
Closed -$111 – 2209
2023
Q1 		$111 Hold
100
– – ﹤0.01% 2162
2022
Q4 		$205 Buy
+100
New +$7.54K ﹤0.01% 2104

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cetera Investment Advisers's BMY Position: Q1 2026 in Review

Cetera Investment Advisers increased its Bristol-Myers Squibb (BMY) stake by 5.2% in Q1 2026, buying an estimated $2.38M and bringing the position to 822,948 shares worth $49.9M. The position accounts for 0.05% of the portfolio, ranked #366.

Cetera Investment Advisers first reported a position in BMY in Q4 2015 and has held it in 42 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Cetera Investment Advisers held 822,948 shares of Bristol-Myers Squibb worth $49.9M as of Q1 2026.
  • Cetera Investment Advisers bought 40,910 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.38M.
  • Bristol-Myers Squibb made up 0.05% of Cetera Investment Advisers's portfolio in Q1 2026, its #366 holding.
  • Cetera Investment Advisers first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 42 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.